These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12729053)

  • 1. Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLE.
    Toubi E; Kessel A; Rosner I; Rozenbaum M; Lorber M; Paran D; Sabo E; Golan TD
    Lupus; 2003; 12(4):297-301. PubMed ID: 12729053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
    Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients.
    Toubi E; Rosner I; Rozenbaum M; Kessel A; Golan TD
    Lupus; 2000; 9(2):92-5. PubMed ID: 10787004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of early cardiac dysfunction in patients with systemic lupus erythematosus with or without anticardiolipin antibodies.
    Barutcu A; Aksu F; Ozcelik F; Barutcu CA; Umit GE; Pamuk ON; Altun A
    Lupus; 2015 Sep; 24(10):1019-28. PubMed ID: 25697770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
    Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Inoue Y; Ueno M; Tanaka Y
    Int J Rheum Dis; 2019 Mar; 22(3):434-442. PubMed ID: 30338639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preterm deliveries in women with systemic lupus erythematosus.
    Clark CA; Spitzer KA; Nadler JN; Laskin CA
    J Rheumatol; 2003 Oct; 30(10):2127-32. PubMed ID: 14528505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
    Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
    Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
    Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
    Borba EF; Saad CG; Pasoto SG; Calich AL; Aikawa NE; Ribeiro AC; Moraes JC; Leon EP; Costa LP; Guedes LK; Silva CA; Goncalves CR; Fuller R; Oliveira SA; Ishida MA; Precioso AR; Bonfa E
    Rheumatology (Oxford); 2012 Jun; 51(6):1061-9. PubMed ID: 22298793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
    McCune WJ; Gonzalez-Rivera T
    Curr Opin Rheumatol; 2015 May; 27(3):213-5. PubMed ID: 25784384
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.
    Levy RA; Vilela VS; Cataldo MJ; Ramos RC; Duarte JL; Tura BR; Albuquerque EM; Jesús NR
    Lupus; 2001; 10(6):401-4. PubMed ID: 11434574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.
    Hanaoka H; Iida H; Kiyokawa T; Takakuwa Y; Kawahata K
    Int J Rheum Dis; 2019 Mar; 22(3):468-472. PubMed ID: 30406967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.